Hanmi Pharm’s ‘Amosartan,’ the hottest seller among improved drugs

Among improved drugs developed by pharmaceutical companies, the hottest seller was observed to be ‘Amosartan,’ a Hanmi Pharm’s hypertension treatment.

‘Amosartan,’ which approved on March 2009, recorded KRW 387.7 billion sales by the first half.

According to the Ministry of Food and Drug Safety, there were the total 52 improved drugs by 19 October 2015, starting with the first improved drug, ...